Literature DB >> 9181392

It is futile to use interferon in HCV-related chronic hepatitis with viremia levels above 3 x 10(6) eq/ml.

F Morisco, C Tuccillo, G Sessa, P Iasevoli, S Scotto di Santolo, C Del Vecchio Blanco, N Caporaso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9181392     DOI： 10.1007/BF02113613

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

Review 1.  Antiviral therapy for chronic hepatitis C viral infection.

Authors:  S Sherlock
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

2.  A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C.

Authors:  K Chayama; A Tsubota; M Kobayashi; M Hashimoto; Y Miyano; H Koike; M Kobayashi; I Koida; Y Arase; S Saitoh; N Murashima; K Ikeda; H Kumada
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

3.  Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.

Authors:  G Yamada; M Takatani; F Kishi; M Takahashi; T Doi; T Tsuji; S Shin; M Tanno; M S Urdea; J A Kolberg
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

4.  Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology.

Authors:  J Detmer; R Lagier; J Flynn; C Zayati; J Kolberg; M Collins; M Urdea; R Sánchez-Pescador
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.

Authors:  M Shindo; A M Di Bisceglie; J H Hoofnagle
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.